AC
IMA

Aldebaran Capital’s ImageneBio Inc IMA Stock Holding History

Aldebaran Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.8K Sell
18,566
-504
-3% -$3.27K 0.07% 43
2025
Q4 		$132K Sell
19,070
-492
-3% -$3.65K 0.12% 34
2025
Q3 		$159K Sell
19,562
-614
-3% -$8.14K 0.15% 32
2025
Q2 		$324K Sell
20,176
-474
-2% -$6.96K 0.32% 30
2025
Q1 		$317K Buy
+20,650
New +$356K 0.3% 32

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aldebaran Capital's IMA Position: Q1 2026 in Review

Aldebaran Capital reduced its ImageneBio Inc (IMA) stake by 2.6% in Q1 2026, selling an estimated $3.27K and leaving 18,566 shares worth $92.8K. The position accounts for 0.07% of the portfolio, ranked #43.

Aldebaran Capital first reported a position in IMA in Q1 2025 and has held it in 5 quarters since. The position peaked at $324K in Q2 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Aldebaran Capital held 18,566 shares of ImageneBio Inc worth $92.8K as of Q1 2026.
  • Aldebaran Capital sold 504 ImageneBio Inc shares in Q1 2026, an estimated $3.27K.
  • ImageneBio Inc made up 0.07% of Aldebaran Capital's portfolio in Q1 2026, its #43 holding.
  • Aldebaran Capital first reported a position in ImageneBio Inc in Q1 2025 and has held it in 5 quarters since.
  • Aldebaran Capital's ImageneBio Inc position peaked at $324K in Q2 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Aldebaran Capital's 13F filing for Q1 2026, filed 7 May 2026.